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ABSTRACT: The novel “double strained alkyne” 3 has been
prepared and evaluated in strain-promoted azide-alkyne
cycloaddition reactions with azides. The X-ray crystallographic
structure of 3, which was prepared in one step from 1,1′-
biphenyl-2,2′,6,6′-tetrol 4, reveals the strained nature of the
alkynes. Dialkyne 3 undergoes cycloaddition reactions with a
number of azides, giving mixtures of regiosiomeric products in
excellent yields. The monoaddition products were not observed or isolated from the reactions, suggesting that the second
cycloaddition proceeds at a faster rate than the ﬁrst, and this is supported by molecular modeling studies. Dialkyne 3 was
successfully employed for “peptide stapling” of a p53-based diazido peptide, whereby two azides are bridged to give a product
with a stabilized conformation.
■ INTRODUCTION
Strained alkynes, i.e., alkynes distorted from the ideal linear
geometry, undergo cycloaddition reactions with azides without
the requirement for a copper catalyst (Scheme 1), in processes
commonly referred to as strain-promoted azide-alkyne cyclo-
addition or “click” reactions.1 As such, their reactions are clean
and require minimal processing during a workup. Moreover,
due to their bioorthogonal nature, strained alkynes have
established themselves as valuable reagents for bioconjugation
reactions,2 for example, the attachment of ﬂuorescent groups
to proteins to track the protein’s movement during biological
processes. Important examples of strained alkynes that have
become commercially available are shown in Figure 1.3
Reagents that contain two strained alkynes oﬀer the
potential to link together two azide-containing functional
groups or to bridge two azides in a single molecule, which
oﬀers the potential, for example, to stabilize the conformation
of a ﬂexible molecule such as a peptide. A good example of this
is the Sondheimer dialkyne 1, which contains two highly
strained alkynes bridged by aromatic rings.4,5 Although 1 was
ﬁrst reported in 1974, it was not applied to a bioconjugation
application until 2010 when Kii et al. employed it to bridge
between a protein-localized halotag-azide and a ﬂuorescent
azide, resulting in successful ﬂuorescent labeling of a protein.6
The reactions of 1 with diazo compounds and furans have
been reported, and the alkyne/alkene derivative has been used
in a cycloaddition with an azide.5 Dialkyne 1 has also been
applied to the macrocyclization of bis-azide functionalized
peptides (“peptide stapling”) by Spring et al.7 It has also been
applied to the control of the tetramerization of HIV-related
peptides.8
In a recent research, we9a,b and others9c reported the
synthesis and applications to azide cycloadditions of the
strained alkyne 2 and its derivatives, which can be prepared in
a short sequence from readily available starting materials. We
also demonstrated that its NHS-ester derivative could be
successfully attached to a protein and subsequently “clicked”
with an azide.9 Inspired by dialkyne 1 and its applications, we
identiﬁed the corresponding biphenol-derived dialkyne 3 for
synthesis and investigation as a dual click reagent (Figure 2).
■ RESULTS AND DISCUSSION
The envisaged strategy of synthesizing the target bis-strained
alkyne 3, a modiﬁcation of the previously reported
monoalkynes,9 required the prior synthesis of the previously
reported tetrahydroxy biphenyl precursor 4 (Scheme 2).10 1,3-
Dimethoxybenzene was reacted with 1,3-dimethoxy-2-iodo-
benzene under Cu(I) catalysis in ethereal pyridine, giving
2,2′,6,6′-tetramethoxy-1,1′-biphenyl 5 in high yield (93%).
The methyl-protecting groups were cleaved using BBr3 in
CH2Cl2 to obtain 1,1′-biphenyl-2,2′,6,6′-tetrol 4 in multigram
quantities (55%). The bis-macrocyclization of the tetrol 4 was
accomplished using ditosylate 6 in anhydrous MeCN using
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K2CO3 under high-dilution conditions (ca. 14 mM) to furnish
3 in reasonable yield (28%) for the challenging cyclization
reaction.9a It was found that changing the concentration or
using a syringe pump to combine the reagents9c did not
improve the yield.
Crystals of 3 were obtained, which were suitable for analysis
by single-crystal X-ray diﬀraction (Figure 3; see the Supporting
Information for full details). The solution conﬁrmed the bis-
strained topology with a biphenyl (C5−C6−C7−C8) dihedral
angle of 69.8(3)° and an average sp bond angle of 165.3°. The
alkynyl moieties thus exhibit a similar degree of distortion
compared with the analogous monocyclic alkynes that have
been studied in the solid state (sp angles typically in the range
of 163.0−167.7°),9 indicating that 1 would be expected to have
a similar reactivity.
Cycloaddition Reactions. Following the synthesis and
characterization of novel bis-strained alkyne 3, cycloaddition
reactions with RN3 (R = -CH2Ph, -octyl) were undertaken to
assess the eﬃcacy of triazole formation (Scheme 3). The
reactions were conducted in CDCl3 (0.1 M, 298 K) and
monitored by 1H NMR spectroscopy (Figure 4 illustrates the
spectra for the addition of octyl azide to give 7; details of
assignments are given in the Supporting Information). Both
cycloaddition reactions were found to proceed with greater
than 90% conversion to the bis-addition products after 72 h (R
= -CH2Ph; 93.2%, -octyl; 95.6%), comparing favorably with
previously reported monoalkynes based on 2. This indicates
that although bis-alkyne 3 displays a degree of alkyne sp bond
strain, in the solid state, similar to previously reported
monoalkynes based on 2, it exhibits enhanced reactivity.
Unexpectedly, the bis-clicked products appeared to be formed
directly, with only a transient observation of what might be the
intermediate monoclick product (resonance ca δ 4.75 at ca. 6
and 24 h, Figure 4), suggesting that the ﬁrst addition is the
rate-determining step. A similar observation was made in
studies on dialkyne 1, speculated to be the result of increased
steric hindrance eﬀects.6 Alternatively, an electronic eﬀect
caused by the oxygen atoms in the ring of the initial addition
product could be inﬂuencing the reaction, making the level of
strain higher in the monocyclization adduct relative to that in 3
and hence the rate of the second cycloaddition step higher
than that of the ﬁrst. Due to the nature of the double addition
reaction, it was not possible to accurately measure the rates of
each step of the cycloaddition; however, in terms of conversion
over time, the apparent rate constant is similar to that
measured for the monocyclic derivatives of 3, i.e., in the order
Figure 1. Well-established strained alkynes and dialkyne 1.
Figure 2. Known alkyne 2 and target bis-strained alkyne 3.
Scheme 2. Synthesis of Target Bis-Strained Alkyne 3
Figure 3. Single-crystal X-ray structure of bis-strained alkyne 3
(ellipsoids plotted at the 50% probability level).
Scheme 3. Synthesis of Bis-Triazoles 7 and 8
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of 10−4 M−1 s−1. Following chromatographic puriﬁcation,
compounds 7 and 8 were isolated in high yield (R = -CH2Ph;
89%, -octyl; 80%) as an inseparable 1:1 mix of syn- and anti-
regioisomers (Scheme 3). Although inseparable, it was possible
to assign the signals of many of the protons in each
regioisomer (see the Supporting Information).
The 1H NMR spectrum of 7 in CDCl3 only indicated
formation of the syn isomer due to the low solubility of anti-7.
The solubility of both isomers in (CD3)2SO conﬁrms the
expected 1:1 mix of regioisomers. See the Supporting
Information for full details. Single crystals of compound anti-
7 were obtained, which were analyzed by X-ray diﬀraction, and
the structure conﬁrmed that the compound preferentially
crystallized exclusively as the anti-isomer but as a racemic
mixture of enantiomers (Figure 5; see the Supporting
Information for full detail). The solution of 7 exhibits a
signiﬁcant diminution of biphenyl torsion compared with the
parent bis-alkyne 3 ([C5−C6−C7−C8]: 7; 60.6°, 3; 110.2°
for the comparable angle), reﬂecting the less strained topology
granted by the formed sp2 triazole.
In addition, we investigated the cycloaddition reaction of a
PEG-1000 diazide with 3, with the potential for formation of
an addition polymer. Due to the large molecular mass of the
PEG-1000, this was carried out with higher dilution than for
the small molecule azides. However, a successful double-click
reaction was observed, and the product was characterized by
gel permeation chromatography (GPC), with full details given
in the Supporting Information.
Computational Studies of the Cycloaddition. To
understand the kinetics of the cycloaddition more clearly,
some molecular modeling studies were carried out using
Gaussian 0914 with the B3LYP density functional and the 6-
31G(d) basis set within the CPCM model at standard
conditions (see the Supporting Information for full computa-
tional details).11,6 The ﬁrst cycloaddition, leading to the
formation of the monotriazole intermediate 9, was found to be
the rate-determining step as the results indicated that the
second cycloaddition reaction, to both the syn and anti
Figure 4. 1H NMR (400 MHz, 298 K, CDCl3) azide-alkyne cycloaddition of 3 with 2.0 equiv of octyl azide. The doublet at ca. δ 4.75 may
correspond to transient formation of the monoadduct.
Figure 5. Single-crystal X-ray structure of anti-7 (ellipsoids plotted at
the 50% probability level, H-atoms and solvate omitted for clarity).
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products, required a lower energy barrier than the ﬁrst by 0.8−
1.0 kcal/mol (Figure 6; full details are given in the Supporting
Information). These results mirror the experimental observa-
tions and also those reported previously for dialkyne 1, for
which a speciﬁc steric interaction was suggested to be
responsible.6 It is likely that a similar phenomenon is operating
here, with the extra steric demands of the newly generated
triazole creating additional strain energy at the remaining
alkyne. This is supported by the molecular modeling studies;
the alkyne bond angle for the biphenyl diyne was calculated to
be 164.6° (which correlates well with the average of 165.3°
measured in the solid state), whereas the angles for the
monotriazole intermediate were 162.4 and 162.5°, respectively.
Peptide Stapling Studies. Given the promising results
described above, some investigations were carried out into the
use of 3 as a reagent for peptide stapling, a process in which a
ﬂexible linear peptide can be “ﬁxed” into a much more stable
conformation by linking two groups in the chain (Figure 7).7,12
A (17−29)p53 peptide (Ac-ETFOrn(N3)DLWRLLOrn(N3)EN-
NH2) was studied. Puriﬁed peptide and bis-alkyne 3 (1.1
equiv) were combined in tBuOH/H2O. The resulting solution
([peptide] = ca. 0.6 mM) was stirred at room temperature for
72 h. After 24 h at room temperature, a small amount of
stapling was observed by ESI-mass spectrometry (ESI-MS).
The stapled peptide product (MW: 2075.28) coelutes with the
LCMS peak of the starting material (MW: 1756.95)
(Supporting Information). We attempted the reaction over
24 h at rt followed by 24 h at 37 °C, but the reaction did not
reach completion. At 48 h, another 1.5 equiv of linker was
added, while maintaining the reaction stirring at 37 °C.
Maintaining the temperature at 37 °C gave better results;
however, conversion to the stapled peptide was incomplete and
some starting material was still observed after 72 h (full details
are in the Supporting Information). These results indicate that
although 3 is less reactive than dialkyne 1,6−8 it has the
potential to be used successfully as a “peptide stapling” reagent
and will react even at the low concentrations required for this
type of reaction. To conﬁrm that both azides on the peptide
had reacted, IR spectra were recorded; the disappearance of
the azide stretch at 2097 cm−1 was observed (Supporting
Information). The increased reactivity of the second cyclo-
addition, coupled to its intramolecular nature, is likely to be
facilitating the ring-closure process. It is likely that a mixture of
syn- and anti-regioisomers was formed (see the Supporting
information).
■ CONCLUSIONS
In summary, we have reported the synthesis of a novel bis-
strained alkyne compound 3 in three steps from readily
available commercial reagents. Dialkyne 3 was demonstrated to
be capable of cycloaddition reactions with azides in high
conversion (>90%) without the requirement for the use of a
catalyst. The rate of the cycloadditions with 3 was signiﬁcantly
lower than with diyne 1, for which double cycloadditions are
reported to be complete within 1−4 h at rt6,7 (the rate
constant has been measured as (6.29 ± 0.05) × 10−2 M−1 s−1
in MeOH at 25 °C).6 X-ray crystallographic studies of 3 and
anti-7 reveal the decrease in strain upon cycloaddition of azide,
the main driving force for the reaction. Computational studies
supported the experimental observation of a slower ﬁrst
cycloaddition, representing the rate-determining step. The new
bis-strained alkyne 3 has been used in preliminary stapling
experiments, demonstrating its potential applications to this
application. Although again 3 is less reactive than diyne 1 in
this application, an excess of dialkyne 3 was required, with
warming, whereas an analogous peptide stapling reaction with
1.1 equiv of 1 was reported to be complete within 16 h at rt.7a
However, reagent 3 also reacts without the need for a copper
Figure 6. Transition-state structures and activation free energies in kcal/mol for ﬁrst (T1) and second cycloaddition (T2 for syn-regioisomer, T3
for anti-regioisomer) of dialkyne 3 with benzyl azide in methanol.
Figure 7. Peptide stapling of Ac-ETFOrn(N3)DLWRLLOrn(N3)EN-NH2 using 3. The regiochemistry of the product has not been unambiguously
established.
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catalyst and can therefore deliver clean products without the
requirement to remove metal residues, which is the principle
advantage of strained alkynes over unstrained ones. Fur-
thermore, it can be prepared in one synthetic step from a
readily available starting material. In situations where the
highest reaction rates are not required, this potentially makes it
a synthetically valuable alternative to 1. Studies continue to
deﬁne the scope of this reagent and to isolate and study the
properties of the stapled peptide.
■ EXPERIMENTAL SECTION
Compounds 4 and 5 were prepared as previously described
following the published methods and their spectra matched
those reported.10 General experimental details, conversion/
time graphs and related spectra, and GPC details are given in
the Supporting Information.
General Experimental Details. All solvents and reagents
were degassed before use and all reactions were carried out
under a nitrogen atmosphere. Reactions were monitored by
thin-layer chromatography using aluminum-backed silica gel 60
(F254) plates, visualized using UV 254 nm and phosphomo-
lybdic acid or potassium permanganate dips as appropriate.
Flash column chromatography was carried out routinely on
silica gel. Reagents were used as received from commercial
sources unless otherwise stated. Copper(I) iodide was dried at
120 °C for 18 h under dynamic vacuum and stored under N2,
protected from light. Dry solvents were purchased and used as
received. 1H NMR spectra were recorded on a Bruker DPX
(400 or 500 MHz) spectrometer. Chemical shifts are reported
in δ units, parts per million relative to the singlet at 7.26 ppm
for chloroform and 0.00 ppm for tetramethylsilane. Mass
spectra were recorded on a Bruker Esquire2000 ESI or a
Bruker MicroTOF mass spectrometer. Coupling constants (J)
are measured in hertz. IR spectra were recorded on a
PerkinElmer Spectrum One FT-IR Golden Gate. Melting
points were recorded on a Stuart Scientiﬁc SMP 1 instrument
and are uncorrected.
Synthesis of Bis-Alkyne 3.
1,1′-Biphenyl-2,2′,6,6′-tetrol (150 mg, 0.687 mmol) was added
to but-2-ene ditosylate (568 mg, 1.44 mmol) and K2CO3 (474
mg, 3.43 mmol) in acetonitrile (50 mL, ca. 14 mM), and the
mixture was stirred at ambient temperature for 19 days. The
solvent was removed under reduced pressure, followed by
addition of H2O (30 mL), extraction with CH2Cl2 (3 × 30
mL), and drying (MgSO4). Removal of the solvent under
reduced pressure gave yellow oil, which was subsequently
puriﬁed by silica gel column chromatography (EtOAc/hexane
20:80 → 40:60) to aﬀord a white solid. This crude solid was
recrystallized from hot EtOH, which was subsequently cooled
to 4 °C, ﬁltered, and washed with ice cold EtOH to aﬀord
white X-ray diﬀraction quality crystals of the title compound as
a racemic mixture (60 mg, 0.18 mmol, 28%). Mp 222−230 °C
(dec); (found (ESI): [M + Na]+, 341.0786. C20H14O4
+
requires [M + Na]+, 341.0784); νmax 2938, 2885, 1549, 1061
and 831 cm−1; δH (500 MHz, CDCl3) 7.43 (2H, t, J 8.1, ArH),
7.03 (4H, d, J 8.1, ArH), 4.58−4.46 (4H, m, OCH2), 4.43−
4.33 (4H, m, OCH2); δC (126 MHz, CDCl3) 156.08 (ArO),
130.01 (ArH), 128.67 (ArC), 118.54 (ArH), 87.12 (CC),
63.56 (OCH2); m/z (ESI) 341 (M
+ + Na, 100%) and 659
(2M+ + Na, 100).
Synthesis of Bis-Benzyl Triazole 7.A solution of 3 (15.9 mg,
0.05 mmol) and benzyl azide (13.3 mg, 0.10 mmol) in CDCl3
(0.5 mL, 100 mM) was prepared with a J. Young’s NMR tube.
In situ analysis by NMR spectroscopy indicated formation of
the desired bis-triazole compounds within 72 h at ambient
temperature. After 5 days, the solvent was removed in vacuo
and puriﬁed by column chromatography (SiO2; EtOAc/
hexane; 20:80 → 50:50) to obtain a 1:1 mixture of
regioisomers as a white solid (26 mg, 0.044 mmol, 89%).
Note: Due to the insolubility of anti-regioisomer in CDCl3
(this crystallizes from solution and the provided material for
the X-ray crystal structure given below), the NMR data is given
only for the syn isomer. However, both syn- and anti-isomers
are soluble and observable in (CD3)2SO. Mp 140−143 °C;
(found (ESI): [M + Na]+, 607.2068, C34H28N6O4
+ requires
[M + Na]+, 607.2064); νmax 1590, 1573, 1451, 1071, 704 and
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671 cm−1; δH (600 MHz, CDCl3) 7.34 (6H, m, ArH, H
i and
Hj), 7.18 (1H, t, J 8.2, ArH, Ha/c), 7.17−7.13 (4H, m, ArH,
HH), 6.98 (1H, t, J 8.2, ArH, Ha/c), 6.82 (2H, d, J 8.3, ArH,
Hb/d), 6.44 (2H, d, J 8.4, ArH, Hb/d), 5.71 (2H, d, J 15.7,
OCH2, H
g/g′), 5.41 (2H, d, J 13.5, OCH2, He/f), 5.37 (2H, d, J
15.6, OCH2, H
g/g′), 5.27 (2H, d, J 13.5, OCH2, He′/f′), 5.14
(2H, d, J 13.3, OCH2, H
e/f), 4.98 (2H, d, J 13.4, OCH2,
He′/f′); δH (500 MHz, (CD3)2SO) 7.40−7.33 (12H, m, ArH,
Hi, Hj, Hη, and Hτ), 7.29−7.26 (9H, m, ArH, HH, Hγ, and
Ha/c), 7.05 (2H, t, J 8.2, ArH, Hα), 6.92 (2H, d, J 8.2, ArH,
Hb/d), 6.86 (3H, m, ArH, Hβ/χ and Ha/c), 6.64 (4H, app. t, J
8.8, Hb/d and Hβ/χ), 5.76 (4H, dd, J 15.6, 2.6, OCH2, H
f/e or
Hδ/ε), 5.67 (4H, d, J 15.5, OCH2, H
f′/e′ or Hδ′/ε′), 5.45 (4H,
dd, J 14.4, 2.3, OCH2, H
f/e or Hδ/ε), 5.41−5.30 (8H, m, OCH2
and ArCH2, H
f′/e′ or Hδ′/ε′ and Hg/φ), 5.08 (2H, d, J 12.4, 5.8,
ArCH2, H
f/e or Hδ/ε), 5.06 (2H, d, J 12.4, 5.8, ArCH2, H
f′/e′ or
Hδ′/ε′); δC (151 MHz, CDCl3) 157.97 (ArO), 156.52 (ArO),
144.83 (Tz), 134.81 (ArBenzyl), 132.30 (Tz), 129.32 (ArBenzyl),
129.13 (ArH), 128.74 (ArH), 127.23 (ARBenzyl), 127.19
(ArBenzyl), 118.51 (Ar), 115.54 (Ar), 111.30 (ArH), 108.99
(ArH), 63.33 (OCH2), 61.12 (OCH2), 52.52 (PhCH2); δC
(126 MHz, (CD3)2SO) 158.08 (ArO, C
syn/anti), 157.97 (ArO,
Csyn/anti), 156.33 (ArO, Csyn/anti), 156.21 (ArO, Csyn/anti),
143.37 (Tz, Csyn/anti), 143.34 (Tz, Csyn/anti), 135.66 (Tz,
Csyn/anti), 135.63 (Tz, Csyn/anti), 133.33 (ArH, Csyn/anti), 128.85
(ArH, Csyn/anti), 128.80 (ArH, Csyn/anti), 128.78 (ArH, Csyn/anti),
128.60 (ArH, Csyn/anti), 128.34 (ArH, Csyn/anti), 128.14 (ArH,
Csyn/anti), 128.12 (ArH, Csyn/anti), 127.67 (ArH, Csyn/anti),
116.94 (Ar, Canti), 116.58 (ArH, Canti), 116.30 (ArH, Csyn),
111.02 (ArH, Csyn/anti), 110.82 (ArH, Csyn/anti), 108.47 (ArH,
Csyn/anti), 108.36 (ArH, Csyn/anti), 64.88 (ArCH2, C
syn/anti),
64.76 (ArCH2, C
syn/anti), 59.05 (OCH2, C
syn/anti), 58.93
(OCH2, C
syn/anti), 50.95 (OCH2, C
syn/anti), 50.93 (OCH2,
Csyn/anti); m/z (ESI) 585 (M+ + H, 78%) and 607 (M+ + Na,
100).
Synthesis of Bis-Octyl Trizole 8.A solution of 3 (15.9 mg,
0.05 mmol) and benzyl azide (15.5 mg, 0.10 mmol) in CDCl3
(0.5 mL, 100 mM) was prepared with a J. Young’s NMR tube.
In situ analysis by NMR spectroscopy indicated formation of
the desired bis-triazole compounds within 72 h at room
temperature. After 6 days, the solvent was removed in vacuo
and puriﬁed by preparative thin-layer chromatography (SiO2;
EtOAc/hexane; 50:50) to obtain a 1:1 mixture of regioisomers
as a white solid (25 mg, 0.040 mmol, 80%). Mp 105−107 °C;
(found (ESI): [M + Na]+, 651.3642. C36H48N6O4
+ requires
[M + Na]+, 651.3629); νmax 2926, 2855, 1591, 1453, 1222,
1069, 777, and 718 cm−1; δH (500 MHz, CDCl3) 7.33 (1H, t, J
8.2, ArH, Ha/c), 7.22 (2H, t, J 8.2, ArH, Hα), 7.12 (1H, t, J 8.4,
ArH, Ha/c), 6.95 (2H, d, J 8.4, ArH, Hβ,χ), 6.90 (2H, d, J 8.1,
ArH, Hb/d), 6.78 (2H, d, J 8.4, ArH, Hb/d), 6.72 (2H, d, J 8.1,
ArH, Hβ,χ), 5.59 (2H, d, J 14.1, OCH2, H
e/f), 5.50 (2H, d, J
14.0, OCH2, H
e′/f′), 5.33 (2H, d, J 12.6, OCH2, Hδ/ε), 5.28
(2H, d, J 12.6, OCH2, H
δ′/ε′), 5.25 (2H, d, J 14.1, OCH2,
He/f), 5.21 (2H, d, J 14.0, OCH2, H
e′/f′), 5.03 (2H, d, J 12.6,
OCH2, H
δ/ε), 4.98 (2H, d, J 12.6, OCH2, H
δ′/ε′), 4.33−4.26
(8H, m, TzCH2, H
g and Hφ), 1.88−1.78 (8H, m, CH2, HH and
Hγ), 1.28−1.18 (40H, m, CH2, Hi‑m and Hη‑λ), 0.87 (6H, t, J
7.0, CH3, H
n/μ), 0.86 (6H, t, J 7.1, CH3, H
n/μ); δC (126 MHz,
CDCl3) 158.84 (ArO, C
anti), 158.74 (ArO, Csyn), 155.94 (ArO,
Csyn), 155.83 (ArO, Canti), 144.43 (Tz, Csyn/anti), 144.41 (Tz,
Csyn/anti), 131.68 (Tz, Csyn/anti), 131.60 (Tz, Csyn/anti), 129.29
(Ar, Csyn), 129.23 (Ar, Canti), 129.13 (Ar, Csyn), 119.58 (Ar,
Csyn), 117.33 (Ar, Canti), 115.10 (Ar, Csyn), 112.81 (ArH, Csyn),
111.38 (ArH, Canti), 109.51 (ArH, Canti), 108.14 (ArH, Csyn),
62.48 (OCH2, C
syn/anti), 62.32 (OCH2, C
syn/anti), 62.04
(OCH2, C
syn/anti), 61.99 (OCH2, C
syn/anti), 48.67 (TzCH2,
Csyn/anti), 48.63 (TzCH2, C
syn/anti) 31.82 (CH2, C
syn/anti), 31.80
(CH2, C
syn/anti), 30.72 (CH2, C
syn/anti), 30.70 (CH2, C
syn/anti),
29.16 (CH2, C
syn/anti), 29.14 (CH2, C
syn/anti), 29.07 (CH2,
Csyn/anti), 29.05 (CH2, C
syn/anti), 26.60 (CH2, C
syn/anti), 26.57
(CH2, C
syn/anti), 22.73 (CH2, C
syn/anti), 14.21 (CH3, C
syn/anti);
m/z (ESI) 630 (M+ + H, 43%) and 652 (M+ + Na, 100).
Polyoxyethylene Diazide (MW = 2000) Addition. A
solution of 1 (5.0 mg, 15.7 μmol) and PEG-2000 polyoxy-
ethylene diazide (MW = 2000) (31.4 mg, 15.7 μmol) in
CDCl3 (0.5 mL, 0.33 mM) was prepared with a J. Young’s
NMR tube. In situ analysis by NMR spectroscopy indicated
formation of a polymeric species. The conversion after 7 days
was determined to be 86% by integration of the starting
material versus the polymeric product. GPC analysis indicated
the formation of a product of Mn 13 000, Mw 186 000, and PDi
14.25.
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